Article
Immunotherapeutic IL-6R and Targeting the MCT-1/IL-6/CXCL7/PD-L1 Circuit Prevent Relapse and Metastasis of Triple-Negative Breast Cancer
2023-08-22
Abstract excerpt
<h4>Background: </h4> Multiple copies in T-cell malignancy 1 (MCT-1) is a prognostic biomarker for aggressive breast cancers. Overexpressed MCT-1 stimulates the IL-6/IL-6R/gp130/STAT3 axis, which promotes epithelial-to-mesenchymal transition, cancer stemness and tumor progression. <h4>Methods: </h4> We studied the mechanism underlying triple-negative breast cancer (TNBC) immunity and aggressiveness and assessed pr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7b6e009e-f857-5eee-93b1-fc2cf5f133d8
- DOI
- 10.21203/rs.3.rs-3270568/v1
